ACM Biolabs Further Strengthens Leadership, Appoints David Lawrence to Board of Directors
SINGAPORE, April 11, 2023 /PRNewswire/ -- ACM Biolabs (FR0012596468 - ALSEN) a pioneering Singaporean-Swiss biotechnology company, which specializes in the development of targeted therapeutics
France General David Lawrence Madhavan Nallani Boards Of Enterobiotix Synpromics Ltd Business Development
Source: finanznachrichten.de